Kothari Fermentation FY26 net loss widens to ₹298.93 lakh
- Net loss widened to ₹298.93 lakh in FY26 from a profit of ₹80.99 lakh in FY25
- Revenue declined 1.84% to ₹11,213.19 lakh despite a 5.38% rise in production volumes
- Operating margin contracted sharply to 0.21% from 4.77% due to higher raw material costs
- The 36th AGM is scheduled for September 30, 2026, to approve revised promoter remuneration

*this image is generated using AI for illustrative purposes only.
Kothari Fermentation & Biochem reported a net loss of ₹298.93 lakh for FY26, reversing the ₹80.99 lakh profit from FY25. Revenue fell 1.84% to ₹11,213.19 lakh amid rising input costs and pricing pressure. The company has confirmed its 36th Annual General Meeting (AGM) will be held on September 30, 2026.
The AGM notice, published in Financial Express and Jansatta on September 8, 2026, confirms the meeting will take place via video conference or other audio-visual means at 11:30 am. This disclosure complies with Regulations 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance
The operating profit margin contracted sharply to 0.21% from 4.77% in FY25. Profit before tax swung to a loss of ₹346.23 lakh from a profit of ₹193.86 lakh. Finance costs rose marginally to ₹369.93 lakh, while depreciation increased to ₹700.24 lakh. The current ratio improved to 1.91 from 1.08 due to lower current liabilities.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue | ₹11,213.19 lakh | ₹11,423.10 lakh | -1.84% |
| PBT | (₹346.23) lakh | ₹193.86 lakh | Turn to loss |
| Net Profit/Loss | (₹298.93) lakh | ₹80.99 lakh | Turn to loss |
| Production (MT) | 16,102 | 15,280 | +5.38% |
What the Numbers Show
Despite a 5.38% rise in production volume, revenue declined, signaling compressed average selling prices or a shift to lower-margin products. Operating profit before interest and tax (PBDIT) dropped significantly to ₹723.94 lakh from ₹1,196.51 lakh, indicating that volume growth could not offset rising costs. Foreign exchange earnings fell to nil from ₹180.50 lakh in FY25, suggesting reduced export activity.
Corporate Governance and Remuneration
The AGM will seek approval for revised remuneration for Chairman and Managing Director Pramod Kumar Kothari and Whole-Time Director Kavita Devi Kothari, effective April 1, 2026, to March 31, 2028. Mr. Kothari’s proposed monthly salary is ₹6,00,000, while Mrs. Kothari’s is ₹5,75,000. Both packages include minimum remuneration provisions regardless of profitability.
Dr. Rajiv Agarwal resigned as an Independent Director on August 13, 2025. Varun Kumar was appointed as an Additional Director and subsequently as an Independent Director on September 30, 2025. The company did not recommend a dividend for FY26.
Historical Stock Returns for Kothari Fermentation & Biochem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.33% | -3.14% | -3.10% | +18.90% | -14.13% | -36.17% |
What specific strategies will management implement to reverse the decline in average selling prices and restore operating margins in FY27?
How will the complete loss of foreign exchange earnings impact the company's future export strategy and currency risk hedging policies?
Will the board justify the proposed fixed remuneration for top executives despite the company posting a net loss and zero dividend?


































